The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application SA Lauer, KH Grantz, Q Bi, FK Jones, Q Zheng, HR Meredith, AS Azman, ... Annals of internal medicine 172 (9), 577-582, 2020 | 7752 | 2020 |
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study S Stringhini, A Wisniak, G Piumatti, AS Azman, SA Lauer, H Baysson, ... The Lancet 396 (10247), 313-319, 2020 | 1258 | 2020 |
Age-specific mortality and immunity patterns of SARS-CoV-2 M O’Driscoll, G Ribeiro Dos Santos, L Wang, DAT Cummings, AS Azman, ... Nature 590 (7844), 140-145, 2021 | 1236 | 2021 |
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients AS Iyer, FK Jones, A Nodoushani, M Kelly, M Becker, D Slater, R Mills, ... Science Immunology, 2020 | 696 | 2020 |
Long-Term Efficacy of a Hepatitis E Vaccine AS Azman, FJ Luquero, I Ciglenecki N Engl J Med 2015 (372), 2265-2266, 2015 | 445 | 2015 |
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis X Chen, Z Chen, AS Azman, X Deng, R Sun, Z Zhao, N Zheng, X Chen, ... The Lancet Global Health 9 (5), e598-e609, 2021 | 255 | 2021 |
Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland J Perez-Saez, SA Lauer, L Kaiser, S Regard, E Delaporte, I Guessous, ... The Lancet Infectious Diseases 21 (4), e69-e70, 2021 | 251 | 2021 |
Household COVID-19 risk and in-person schooling J Lessler, MK Grabowski, KH Grantz, E Badillo-Goicoechea, CJE Metcalf, ... Science 372 (6546), 1092-1097, 2021 | 240 | 2021 |
Global landscape of SARS-CoV-2 genomic surveillance and data sharing H Yu, Z Chen, A Azman, X Chen, J Zou, Y Tian, R Sun, X Xu, Y Wu, W Lu, ... Nature genetics, 2021 | 221* | 2021 |
The incubation period of cholera: A systematic review AS Azman, KE Rudolph, DAT Cummings, J Lessler Journal of Infection 66 (5), 432-438, 2013 | 207 | 2013 |
Cholera epidemic in Yemen, 2016–18: an analysis of surveillance data A Camacho, M Bouhenia, R Alyusfi, A Alkohlani, MAM Naji, ... The Lancet Global Health 6 (6), e680-e690, 2018 | 206 | 2018 |
The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study S Truelove, O Abrahim, C Altare, SA Lauer, KH Grantz, AS Azman, ... PLoS medicine 17 (6), e1003144, 2020 | 197 | 2020 |
Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models RMGJ Houben, NA Menzies, T Sumner, GH Huynh, N Arinaminpathy, ... The Lancet Global Health 4 (11), e806-e815, 2016 | 190 | 2016 |
Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales J Lessler, SM Moore, FJ Luquero, HS McKay, R Grais, M Henkens, ... The Lancet 391 (10133), 1908-1915, 2018 | 178 | 2018 |
Genomic insights into the 2016–2017 cholera epidemic in Yemen FX Weill, D Domman, E Njamkepo, AA Almesbahi, M Naji, SS Nasher, ... Nature 565 (7738), 230-233, 2019 | 166 | 2019 |
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward JE Bryant, AS Azman, MJ Ferrari, BF Arnold, MF Boni, Y Boum, K Hayford, ... Science immunology 5 (47), eabc6347, 2020 | 164 | 2020 |
Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 A Deshpande, MK Miller-Petrie, PA Lindstedt, MM Baumann, KB Johnson, ... The Lancet Global Health 8 (9), e1162-e1185, 2020 | 148 | 2020 |
Clinical and epidemiological aspects of diphtheria: a systematic review and pooled analysis SA Truelove, LT Keegan, WJ Moss, LH Chaisson, E Macher, AS Azman, ... Clinical Infectious Diseases 71 (1), 89-97, 2020 | 144 | 2020 |
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis Q Bi, E Ferreras, L Pezzoli, D Legros, LC Ivers, K Date, F Qadri, L Digilio, ... The Lancet Infectious Diseases 17 (10), 1080-1088, 2017 | 144 | 2017 |
Neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants induced by natural infection or vaccination: a systematic review and … X Chen, Z Chen, AS Azman, R Sun, W Lu, N Zheng, J Zhou, Q Wu, ... Clinical Infectious Diseases 74 (4), 734-742, 2022 | 133* | 2022 |